Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Prothena Corporation plc Ordinary Shares (PRTA)

Pharmaceutical Preparations

https://www.prothena.com

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS
DUBLIN 2, L2

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/18/2012

Market Cap

1,116,210,127

Shares Outstanding

53,670,000

Weighted SO

53,665,349

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

SCPH --.--%

MIST --.--%

ONCY --.--%

MCRB --.--%

LIFE --.--%

ETNB --.--%

MDGL --.--%

PLRX --.--%

ACLX --.--%

Beta

0.2040

Last Div

0.0000

Range

18.69-58.47

Chg

-0.1150

Avg Vol

483951

Mkt Cap

1116210127

Exch

NASDAQ

Country

IE

Phone

353 1 236 2500

DCF Diff

53.1516

DCF

-25.9316

Div Yield

0.0000

P/S

5.1380

EV Multiple

-6.6533

P/FV

1.9177

Div Yield %

0.0000

P/E

-21.9146

PEG

-0.8665

Payout

0.0000

Current Ratio

12.5359

Quick Ratio

12.5359

Cash Ratio

12.0684

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

184.4265

CCC

-184.4265

Gross Margin

0.9154

Op Margin

-0.4205

Pretax Margin

-0.2826

Net Margin

-0.2344

Eff Tax Rate

0.1706

ROA

-0.0789

ROE

-0.0900

ROCE

-0.1526

NI/EBT

0.8294

EBT/EBIT

0.6720

EBIT/Rev

-0.4205

Debt Ratio

0.0188

D/E

0.0208

LT Debt/Cap

0.0161

Total Debt/Cap

0.0204

Int Coverage

-13.9499

CF/Debt

-8.1196

Equity Multi

1.1094

Rec Turnover

0.0000

Pay Turnover

1.9791

Inv Turnover

0.0000

FA Turnover

13.9690

Asset Turnover

0.3365

OCF/Share

-1.8298

FCF/Share

-1.8714

Cash/Share

10.4920

OCF/Sales

-0.4529

FCF/OCF

1.0227

CF Coverage

-8.1196

ST Coverage

-38.1484

CapEx Coverage

-44.0000

Div&CapEx Cov

-44.0000

P/BV

1.9177

P/B

1.9177

P/S

5.1380

P/E

-21.9146

P/FCF

-11.0932

P/OCF

-11.3425

P/CF

-11.3425

PEG

-0.8665

P/S

5.1380

EV Multiple

-6.6533

P/FV

1.9177

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 17, 23:10 Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm Zacks Investment Research Nov 02, 18:25 Prothena (PRTA) Beats Q3 Earnings and Revenue Estimates Benzinga Oct 23, 11:00 Expert Ratings for Prothena Corp Benzinga Oct 23, 11:00 Expert Ratings for Prothena Corp

Revenue Product Segmentation